Antag Therapeutics Headquarters: Denmark Technology: GIPR antagonist Lead candidate: AT-7687 Focused on bringing its peptide-based therapies to market, Danish biotech company Antag Therapeutics aims to treat obesity and type 2 diabetes with its medicines
Costs can differ based on dosage, vendor, and whether the peptides are combined with other therapies, such as testosterone replacement, in research protocols
Treatment of NTS with inhibitors 1, 2, 4, 7 , and 8 , positive control AF, or negative control 12 for 2 h was followed by addition of TRFS-Green
48-49 (2014) 113-117 Infective endocarditis (IE) is an inflammation of the endothelial lining of the heart muscle, valves and great vessels
A., Diaz, R., Castellana, N., Bhattacharya, I., Gerstein, H